QQ客服 官方微博 反馈留言

	Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
	Xu, Bo; Yang, Yuejin; Han, Yaling; Huo, Yong; Wang, Lefeng; Qi, Xiangqian; Li, Jifu; Chen, Yundai; Kuo, Hai-Chien; Ying, Shih-Wa
刊名	EUROINTERVENTION
	2018
卷号	14期号:5页码:554-561
关键词	bioresorbable scaffolds clinical research clinical trials
DOI	10.4244/EIJ-D-17-00796
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4565481
专题	山东大学
作者单位	Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, 167 Bei Lishi Lu, Beijing 100037, Peoples R China.
推荐引用方式 GB/T 7714	Xu, Bo,Yang, Yuejin,Han, Yaling,et al. Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial[J]. EUROINTERVENTION,2018,14(5):554-561.
APA	Xu, Bo.,Yang, Yuejin.,Han, Yaling.,Huo, Yong.,Wang, Lefeng.,...&Geng D.(2018).Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial.EUROINTERVENTION,14(5),554-561.
MLA	Xu, Bo,et al."Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial".EUROINTERVENTION 14.5(2018):554-561.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。